Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347–360. doi:10.1183/09031936.03.00405703
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. doi:10.1164/ajrccm.160.6.9902115
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014;43(5):1289–1297. doi:10.1183/09031936.00110213
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791–1797. doi:10.1164/ajrccm.157.6.9705017
   PubMed Web of Science ®Google Scholar
• Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20(3):539–544. doi:10.1183/09031936.02.00532002
   PubMed Web of Science ®Google Scholar
• Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994;7(10):1793–1797. doi:10.1183/09031936.94.07101793
   PubMed Web of Science ®Google Scholar
• Makita H, Suzuki M, Konno S, et al. Unique Mortality Profile in Japanese Patients with COPD: an Analysis from the Hokkaido COPD Cohort Study. Int J Chron Obstruct Pulmon Dis. 2020;15:2081–2090. doi:10.2147/COPD.S264437
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Fernandez L, Kuo HP, et al. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology. 2011;16(5):825–835. doi:10.1111/j.1440-1843.2011.01982.x
   PubMed Web of Science ®Google Scholar
• Ichinose M, Taniguchi H, Takizawa A, et al. The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies. Int J Chron Obstruct Pulmon Dis. 2016;11:2017–2027.
   PubMed Web of Science ®Google Scholar
• Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62(11):932–937. doi:10.1136/thx.2006.072777
   PubMed Web of Science ®Google Scholar
• Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):44–52. doi:10.1164/rccm.201106-0992OC
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Konno S, et al. Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study. Am J Respir Crit Care Med. 2016;194(11):1358–1365. doi:10.1164/rccm.201602-0353OC
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: https://goldcopd.org. Accessed November 25, 2021. 19, 2021.
   Google Scholar
• Shimizu K, Tanabe N, Tho NV, et al. Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD. Thorax. 2020;75(2):116–122. doi:10.1136/thoraxjnl-2019-213525
   PubMed Web of Science ®Google Scholar
• Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379–387. doi:10.1016/S0009-9260(82)80301-2
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax. 2008;63(11):951–955. doi:10.1136/thx.2007.092858
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest. 2010;137(2):326–332. doi:10.1378/chest.09-0482
   PubMed Web of Science ®Google Scholar
• Tanabe N, Muro S, Hirai T, et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1653–1659. doi:10.1164/rccm.201009-1535OC
   PubMed Web of Science ®Google Scholar
• Tanabe N, Muro S, Tanaka S, et al. Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease. Respir Res. 2012;13(1):31. doi:10.1186/1465-9921-13-31
   PubMedGoogle Scholar
• Tanabe N, Muro S, Sato S, Oguma T, Sato A, Hirai T. Fractal analysis of low attenuation clusters on computed tomography in chronic obstructive pulmonary disease. BMC Pulm Med. 2018;18(1):144. doi:10.1186/s12890-018-0714-5
   PubMedGoogle Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.244
   PubMed Web of Science ®Google Scholar
• Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(3):961–966. doi:10.1164/ajrccm.153.3.8630580
   PubMed Web of Science ®Google Scholar
• Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954–1960. doi:10.1016/j.rmed.2007.04.009
   PubMed Web of Science ®Google Scholar
• Coxson HO, Chan IH, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med. 2004;170(7):748–752. doi:10.1164/rccm.200405-651OC
   PubMed Web of Science ®Google Scholar
• Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59. doi:10.1093/ajcn/82.1.53
   PubMed Web of Science ®Google Scholar
• Laaban JP, Kouchakji B, Dore MF, Orvoen-Frija E, David P, Rochemaure J. Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest. 1993;103(5):1362–1368. doi:10.1378/chest.103.5.1362
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847
   PubMed Web of Science ®Google Scholar
• Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959–967. doi:10.1164/ajrccm.154.4.8887592
   PubMed Web of Science ®Google Scholar
• MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol. 2001;429(1–3):195–207. doi:10.1016/S0014-2999(01)01320-6
   PubMed Web of Science ®Google Scholar
• Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med. 1997;156(2 Pt 1):341–357. doi:10.1164/ajrccm.156.2.9611013
   PubMed Web of Science ®Google Scholar
• Schols AM, Buurman WA. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996;51(8):819–824. doi:10.1136/thx.51.8.819
   PubMed Web of Science ®Google Scholar
• Tanimura K, Sato S, Fuseya Y, et al. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis. Ann Am Thorac Soc. 2016;13(3):334–341. doi:10.1513/AnnalsATS.201507-446OC
   PubMed Web of Science ®Google Scholar
• Tanabe N, Sato S, Tanimura K, et al. Associations of CT evaluations of antigravity muscles, emphysema and airway disease with longitudinal outcomes in patients with COPD. Thorax. 2021;76(3):295–297. doi:10.1136/thoraxjnl-2020-215085
   PubMed Web of Science ®Google Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1055–1060. doi:10.1164/ajrccm.154.4.8887607
   PubMed Web of Science ®Google Scholar
• Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335(25):1897–1905. doi:10.1056/NEJM199612193352507
   PubMed Web of Science ®Google Scholar
• Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med. 2001;164(7):1101–1102. doi:10.1164/ajrccm.164.7.2108039a
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79–83. doi:10.1164/rccm.200506-969OC
   PubMed Web of Science ®Google Scholar
• Alley DE, Metter EJ, Griswold ME, et al. Changes in weight at the end of life: characterizing weight loss by time to death in a cohort study of older men. Am J Epidemiol. 2010;172(5):558–565. doi:10.1093/aje/kwq168
   PubMed Web of Science ®Google Scholar
• Montes M, Tálamo C, Perez-Padilla R, et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med. 2008;102(5):642–650. doi:10.1016/j.rmed.2007.12.025
   PubMed Web of Science ®Google Scholar
• Abe Y, Suzuki M, Makita H, et al. One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study. BMC Pulm Med. 2021;21(1):159. doi:10.1186/s12890-021-01510-w
   PubMed Web of Science ®Google Scholar
• Kato M, Tomii K, Hashimoto K, et al. The IMPACT study - single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: efficacy and safety in a Japanese population. Int J Chron Obstruct Pulmon Dis. 2019;14:2849–2861. doi:10.2147/COPD.S226601
   PubMed Web of Science ®Google Scholar
• Machado FVC, Spruit MA, Coenjaerds M, Pitta F, Reynaert NL, Franssen FME. Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease. Respirology. 2021;26(9):851–860. doi:10.1111/resp.14100
   PubMed Web of Science ®Google Scholar